Patent 7582601 was granted and assigned to Campina (company) on September, 2009 by the United States Patent and Trademark Office.
The novel use of peptides derived from whey protein hydrolysate as active ingredient in a medicament or as food ingredient for elevating the cholescystokinin level in the blood, and for preventing or treatment of overweight and/or obesity, in an animal, including human, in need thereof.